Evidence map›Paper›PMID 19196950›Full record

ArticleAmerican journal of physiology. Gastrointestinal and liver physiology2009

cAMP-GEF cytoprotection by Src tyrosine kinase activation of phosphoinositide-3-kinase p110 beta/alpha in rat hepatocytes.

Anna Gates, Simon Hohenester, M Sawkat Anwer, Cynthia R L Webster

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Gastrointestinal and liver physiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. INTRACELLULAR SIGNALING BY BILE ACIDS.Journal of bio-science · 2012
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Anna GatesDepartment of Clinical Sciences, Tufts Cummings School of Veterinary Medicine, 200 Westboro Rd., North Grafton, MA 01536, USA.
Simon Hohenester
M Sawkat Anwer
Cynthia R L Webster
Tufts University · US

Funding

MECHANISM OF CANALICULAR BILE FORMATION AND CHOLESTASISR01DK033436 · NIDDK · TUFTS UNIVERSITY BOSTON · PI ANWER, MOHAMMED SAWKAT · 1986 to 2010
$4.0M
Role of Protein Kinase C in Isoforms in Bile formation and CholestasisR01DK090010 · NIDDK · TUFTS UNIVERSITY BOSTON · PI ANWER, MOHAMMED SAWKAT · 2010 to 2014
$2.5M
cAMP modulation of bile induced hepatocyte apoptosisR01DK065975 · NIDDK · TUFTS UNIVERSITY BOSTON · PI LEVEILLE-WEBSTER, CYNTHIA R · 2005 to 2009
$1.1M
NIDDK NIH HHS R01 DK-033436NIDDK NIH HHS R01 DK-065975NIDDK NIH HHS R01 DK065975NIDDK NIH HHS R01 DK090010
6 · The paper itself

Abstract

Cyclic AMP protects against hepatocyte apoptosis by a protein kinase A-independent cAMP-GEF/phosphoinositide-3-kinase (PI3K)/Akt signaling pathway. However, the signaling pathway coupling cAMP-GEF with PI3K is unknown. The aim of this study was to investigate the role of Src tyrosine kinases (Src-TYK) and PI3K-p110 isoforms in this pathway. Studies were done in rat hepatocytes using the hydrophobic bile acid glycochenodeoxycholic acid (GCDC) to induce apoptosis. cAMP-binding guanine nucleotide exchange factors (cAMP-GEFs) were selectively activated by using 4-(4-chloro-phenylthio)-2'-O-methyladenosine-3'-5'-cyclic monophosphate (CPT-2-Me-cAMP), which sequentially phosphorylated Src-TYK (within 1 min) followed by Akt (within 5 min). The Src inhibitors PP2 and SU6656 inhibited basal and CPT-2-Me-cAMP-mediated Src and Akt phosphorylation. These inhibitors had no effect on CPT-2-Me-cAMP-mediated activation of Rap GTPases. CPT-2-Me-cAMP induced transient Src dependent autophosphorylation of the epidermal growth factor receptor (EGFR). Inhibition of the EGFR with AG 1478 partially inhibited the ability of CPT-2-Me to phosphorylate Akt. Whereas PP2 completely abolished the protective effect of CPT-2-Me-cAMP in GCDC induced apoptosis, AG 1478 partially inhibited the cytoprotective effect. CPT-2-Me-cAMP treatment resulted in Src-dependent activation of the p110 beta and alpha subunits of PI3K, but only the latter was sensitive to inhibition with AG 1478. In conclusion, activation of cAMP-GEFs results in phosphorylation of Src-TYK and Akt and activation of the p110 beta/alpha subunits of PI3K. Maximal cAMP-GEF-mediated Akt phosphorylation as well as protection from bile acid-induced apoptosis requires activation of Src-TYK and the EGFR. These studies support the existence of two pathways: cAMP-GEF/Rap/Src/PI3Kbeta/Akt and cAMP-GEF/Rap/Src/EGFR/PI3Kalpha/Akt, both of which are necessary for maximal cytoprotective effect of cAMP-GEFs in hepatocytes.

Indexed as

AnimalsApoptosisClass I Phosphatidylinositol 3-KinasesCyclic AMPGene Expression RegulationGlycochenodeoxycholic AcidGuanine Nucleotide Exchange FactorsHepatocytesIsoenzymesMalePhosphatidylinositol 3-KinasesRatsSignal Transductionsrc-Family KinasesClass I Phosphatidylinositol 3-KinasesCyclic AMPGlycochenodeoxycholic AcidGuanine Nucleotide Exchange FactorsIsoenzymesp110delta protein, ratPhosphatidylinositol 3-Kinasessrc-Family Kinases

Identifiers

PMID19196950
PMCPMC2670669
OpenAlexW2118560667

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.